Sign in

CIK 0001680581

  • Non-accelerated filer
  • Smaller reporting company

Fulcrum Therapeutics, Inc.

Sign in to watch
Ticker
FULC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
474839948
Phone
+1 617-651-8851
Business address
26 LANDSDOWNE STREET, CAMBRIDGE, MA, 02139
  1. 4 Grant or award Controller acquired 3,250 shares (grant or award)
  2. 4 Open-market sale Director sold 5,631 shares at $24.02 ($135,228)
  3. 4 Open-market sale Director sold 94,251 shares at an average $24.16 ($2,276,684)
  4. 3 Insider Initial Statement of Ownership
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 3 Insider Initial Statement of Ownership
  12. 5 Insider Annual Insider Trading Report
  13. 4 Derivatives Options or other derivatives
  14. 3 Insider Initial Statement of Ownership
  15. 4 Other disposition Director disposed of 1,000,000 shares (other)
  16. 4 Other disposition 10% owner disposed of 1,000,000 shares (other)
  17. 4 Other disposition Director disposed of 1,000,000 shares (other)
  18. 4 Other disposition 10% owner disposed of 1,000,000 shares (other)
  19. 4 Open-market sale Chief Scientific Officer sold 51,785 shares at an average $17.60 ($911,416)
  20. 4 Open-market sale See Remarks sold 60,000 shares at an average $20.42 ($1,225,000)

Page 6 of 12 · 221 filings